Madorra Enrolls First Patient in Pivotal Trial for Treatment of Moderate to Severe Vulvovaginal Atrophy: The WAVES Study
/
DateApr 02 2026
Breakthrough Device-Designated Therapy System Takes Important Step Toward Market Authorization PORTLAND, OR, UNITED STATES, March 24, 2026 /EINPresswire.com/ — Madorra Inc., a medical device company... Read More →
















